Adline Chem Lab Ltd.

28.70 ▼0%

07 February 2024, 03:30:00 PM

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.kamronlabs.com
Market Cap 16.79 Cr.
Enterprise Value(EV) 18.20 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -0.21 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.89 Trailing Twelve Months Ending 2023-12
Book Value / Share -2.87 Trailing Twelve Months Ending 2023-12
Price to Book Value -10.01 Calculated using Price: 28.70
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.59 Cr. 5,850,000 Shares
FaceValue 10
About Adline Chem Lab Ltd.
The company is engaged primarily in business of manufacturing pharmaceutical products. The company has also stared trading in grey fabrics.

Adline Chem Lab Ltd. Delivery

Delivered Qty
Traded Qty

Adline Chem Lab Ltd. Performance

1 Day
1 Week
1 Month
+8.51%
3 Month
+29.98%
6 Month
+124.92%
1 Year
+431.48%
2 Year
+275.65%
5 Year
+420.87%
10 Year

Adline Chem Lab Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 0.42 0.2 0.21 0.06 1.02 -127.09 -49.89 31.35 -783.45
Return on Capital Employed (%) 3.83 3.16 2.46 2.55 0.93 -49.36 -23.82 16.18 -226.98
Return on Assets (%) 0.13 0.06 0.04 0.01 0.12 -25.58 -19.42 13.66 -171.55

Adline Chem Lab Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 7 7 7 7 7 3 2 3 -2 -2
Non Curr. Liab. 6 5 4 4 0 0 0 0 0 0
Curr. Liab. 6 7 9 12 15 4 3 2 1 1
Minority Int.
Equity & Liab. 19 18 21 23 22 8 6 5 0 0
Non Curr. Assets 12 12 13 13 12 5 4 4
Curr. Assets 6 5 5 7 6 3 2 0 0 0
Misc. Exp. not W/O 1 2 3 4 4
Total Assets 19 18 21 23 22 8 6 5 0 0

Adline Chem Lab Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 15 17 17 8 6 7 6 1
Other Income 0 0 0 0 0 0 0 0 1 0
Total Income 15 17 17 8 6 7 6 1 1 0
Total Expenditure -14 -16 -16 -7 -5 -10 -7 -1 -1 0
PBIDT 1 1 1 1 1 -3 0 0 0 0
Interest 0 0 0 0 0 0 0 0
Depreciation -1 0 -1 -1 -1 0 -1 0 0
Taxation 0 0 0 0 0
Exceptional Items 0 1 -4
PAT 0 0 0 0 -4 -1 1 -4 0
Adjusted EPS 0 0 0 0 -6 -2 1 -7 0

Adline Chem Lab Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 0 1 2 1 -1 -11 0 0 0
Cash Fr. Inv. -1 -2 0 -3 -3 0 11 0
Cash Fr. Finan. 0 2 -1 1 4 0 0 0 0
Net Change 0 0 0 0 2 -2 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 2 0 0 0 0 0

Adline Chem Lab Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 30.17 30.17 30.17 28.24 28.24 28.24 28.24 28.24 28.24
Public 69.83 69.83 69.83 71.76 71.76 71.76 71.76 71.76 71.76
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Adline Chem Lab Ltd. Announcements

Mon, 05 Feb 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hemant A Parikh
Sat, 03 Feb 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hemant A Parikh
Sat, 03 Feb 2024
Announcement under Regulation 30 (LODR)-Change in Directorate
Change in Directors of the Company

Adline Chem Lab Ltd. Technical Scans

No Scans Found

Adline Chem Lab Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 373,756.40 1,561.40 +0.2%
Cipla Ltd. 117,370.75 1,467.70 +1.0%
Dr. Reddy's Laboratories Ltd. 106,155.83 6,443.15 +1.2%
Apollo Hospitals Enterprise Ltd. 97,309.86 6,778.75 +0.1%
Divi's Laboratories Ltd. 96,809.75 3,647.60 +0.1%
Zydus Lifesciences Ltd. 91,584.23 925.40 +2.3%
Torrent Pharmaceuticals Ltd. 88,295.34 2,630.65 +0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.97 1,561.40 +0.2%
Cipla Ltd. Consolidated 2023-12 31.65 1,467.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.30 6,443.15 +1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 123.28 6,778.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 70.00 3,647.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 30.80 925.40 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.10 2,630.65 +0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.99 1,561.40 +0.2%
Cipla Ltd. Consolidated 2023-12 4.53 1,467.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.95 6,443.15 +1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 14.41 6,778.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-12 7.43 3,647.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.71 925.40 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.35 2,630.65 +0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,561.40 +0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,467.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,443.15 +1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,778.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,647.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 925.40 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,630.65 +0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,561.40 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,467.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,443.15 +1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,778.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,647.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.40 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,630.65 +0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,561.40 +0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,467.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,443.15 +1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,778.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,647.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.40 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,630.65 +0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,561.40 +0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,467.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,443.15 +1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,778.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,647.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 925.40 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,630.65 +0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,561.40 +0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,467.70 +1.0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,443.15 +1.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,778.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,647.60 +0.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 925.40 +2.3%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,630.65 +0.9%

Adline Chem Lab Ltd. FAQ's

What is Adline Chem Lab share price?

Can I buy Adline Chem Lab shares now?

What is the Market Cap of Adline Chem Lab?

What is the 52 Week High and Low of Adline Chem Lab?